LACK OF COMPLICATIONS OF HIGH-DOSE INTRAVITREAL TOPOTECAN FOR RECURRENT RETINOBLASTOMA IN 81 CONSECUTIVE INJECTIONS
Based on this analysis, high-dose intravitreal topotecan is safe and effective in the management of recurrent small retinoblastoma in humans. Further investigation of the limits of this therapy is warranted.
Authors
- Taweevat Attaseth
- Robert Medina
- Sara E. Lally
- Carol L. Shields
Institutions
- Thomas Jefferson University (US)
- Wills Eye Hospital (US)
Publication Details
- Journal
- Retina
- Published
- 2025-09-15
- DOI
- https://doi.org/10.1097/iae.0000000000004678
- Primary Topic
- Ocular Oncology and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00